Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. Crucell focuses on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide. Currently we are combating twelve major infectious diseases with our range of marketed vaccines in the paediatric, travel and endemic and respiratory fields.
|Euronext:||€||(15 minute delay)|
|NASDAQ:||$||(15 minute delay)|
|SWX:||CHF||(15 minute delay)|